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Lack of insulin results in a catabolic state in subjects with insulin-dependent diabetes mellitus which is reversed by insulin
treatment. Amino acid supply, especially branched chain amino acids such as leucine, enhances protein synthesis in both animal
and human studies. This small study was undertaken to assess the acute eﬀect of supplemental leucine on protein metabolism
in adolescents with type 1 diabetes. L-[1-13C] Leucine was used to assess whole-body protein metabolism in six adolescent
females (16–18yrs) with type 1 diabetes during consumption of a basal diet (containing 58μmoles leucine/kg/h) and the basal
diet with supplemental leucine (232μmoles leucine/kg/h). Net leucine balance was signiﬁcantly higher with supplemental leucine
(56.33 ± 12.13μmoles leucine/kg body weight/hr) than with the basal diet (−11.7 ±− 5.91, P<. 001) due to reduced protein
degradation (49.54 ±18.80μmoles leucine/kg body weight/hr) compared to the basal diet (109 ±13.05, P<. 001).
1.Introduction
Whole body protein catabolism results when the rate at
which body protein is synthesized is less than the rate at
which body protein is degraded. Insulin is among the many
factors which regulate body protein metabolism. The lack of
insulin associated with type 1 diabetes results in the loss of
body protein, and insulin treatment reverses the loss of body
protein resulting in increased lean body mass [1]. Several
animal studies have demonstrated the importance of insulin
in regulating the rate of protein synthesis particularly in
muscletissue(e.g.,[2–7]).Incontrast,studiesofwhole-body
protein metabolism in adult humans with type 1 diabetes
[8–13] and prepubertal children [14] have suggested that
the primary eﬀect of insulin is a reduction in the rate of
protein degradation rather than a stimulation of the rate of
protein synthesis. While provision of insulin to individuals
with type 1 diabetes enhances the accretion of body protein
mass, there are also data from adults [15] and adolescents
females [16] suggesting that long-term insulin therapy also
results in accumulation of body fat compared to nondiabetic
individuals. The current study was undertaken to determine
if the anabolic eﬀect of insulin on protein metabolism could
be enhanced by the concurrent provision of a diet enriched
with the amino acid, leucine.
In clinical studies, solutions of branched-chain amino
acids have improved nitrogen balance in patients with surgi-
cal stress [17–19]. In patients with liver carcinoma, provision
of branched-chain amino acids has been demonstrated to
result in decreased morbidity and improved quality-of-life
[20], reduced complications following surgery [21], and
decreased length of hospital stay [22]. In healthy subjects,
provision of essential amino acids in both young and old
subjects results in a stimulation of the rate at which muscle
protein is synthesized [23, 24]. In elderly subjects, enriching
the essential amino acid supplement with additional leucine
results in a further stimulation in the rate of muscle
protein synthesis in elderly, but not young subjects [25].
Even in the absence of other essential amino acids, leucine
supplementation has been demonstrated to be suﬃcient
to enhance the rate of muscle protein synthesis in elderly
subjects [26]. In animal studies, leucine alone stimulated
the rate of muscle protein synthesis, although the plasma2 International Journal of Pediatric Endocrinology
Table 1: Subject Characteristics.
Mean ±SEM Range
Gender 6F
Age (y) 16 ±0.4 15–18
Duration of diabetes (y) 10 ±1.54 – 1 5
Height (m) 1.6 ± 0.03 1.5–1.7
Weight (kg) 62.8 ±3.8 55–80
Tanner stage 5 5
Prestudy insulin (U/kg/d) 0.80 ±0.04 0.7–0.98
Hemoglobin A1C (%) 8.6 ±0.6 7.1–10.5
concentrations of insulin were also increased when leucine
was given [27]. When the increase in insulin secretion was
prevented, the ability of leucine to stimulate the rate of
muscle protein synthesis was also blocked [27] suggesting
that the change in protein synthesis was insulin dependent.
In contrast, in another study, leucine has been shown to
stimulate the rate of muscle protein synthesis in diabetic
animals suggesting that there is also an insulin-independent
mechanism for the ability of leucine to stimulate muscle
protein synthesis [28].
Thecurrentstudywasundertakentodetermineifadoles-
cents with type 1 diabetes respond to leucine supplementa-
tion of a complete diet with an increase in protein retention.
If leucine were able to increase net protein retention, then
there may be a role for increasing the leucine content of the
diet for adolescents with type 1 diabetes.
2. Methods
2.1. Protocol. The study was conducted in 6 adolescent
females with type 1 diabetes (Table 1). The subjects were
studied over a 48-hour period at the General Clinical
Research Center of Stony Brook University Medical Center.
Subjects were admitted the evening preceding two sequential
study days. The protocol was approved by the Committee of
ResearchInvolvingHumanSubjects,theInstitutionalReview
Board. Written consent from the parents of minors and
written consent or assent from the subjects was obtained
after explaining the purpose, nature, and potential risks of
the study. A urine pregnancy test was done on all subjects to
exclude pregnancy.
The two study days consisted of six-hour periods begin-
ning at 7 AM afteran overnight fast. The two study days were
consecutive to minimize any impact of menstrual cycle on
protein metabolism. During the study periods, the subjects
consumed hourly meals of Carnation Ready-to-Eat Instant
Breakfast with 19% of calories from fat, 57% of calories
from carbohydrate, and 22% from protein. The hourly
meals contained 1/12 of the individual subject’s daily caloric
requirement (resting energy expenditure from [29] ×1.6).
Subjects randomly consumed the basal diet on one study
day and the basal diet with added L-leucine (Ajinomoto, Inc,
Raleigh, NC) on the other study day. Leucine intake from
the basal diet was 58μmoles/kg/h (or 7mg/kg/h) and with
added leucine the dietary intake of leucine was 232μmoles
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Figure 1: Plasma glucose concentrations in type 1 diabetic
adolescent girls consuming a basal diet or a diet supplemented
with L-leucine. Plasma concentrations of glucose (mg/dl) during
consumption of the basal diet (19% of calories from fat, 57% of
calories from carbohydrate, and 22% fromprotein) orthebasal diet
with supplemental L-leucine (total leucine content of 4 times the
basal diet).
(30mg)/kg/h. All subjects discontinued their subcutaneous
insulin infusion via insulin pump on the morning of study
and were maintained on an insulin drip with a bolus
of 0.05–0.1units/kg and 0.025–0.15units/kg/hr to maintain
plasma glucose between 80–180mg/dL. Plasma glucose was
monitored every 15 minutes and the rate of insulin infusion
adjusted to maintain plasma glucose in the desired range
(Beckman II Glucose Analyzer).
L-[1-13C] leucine (Cambridge Isotopes, Andover, MA)
was infused intravenously to assess whole-body protein
kineticsasdescribedpreviouslyforexample[30,31].Labeled
leucine was given as a bolus of 6μmoles per kg body
weight followed by a continuous infusion of 6μmoles per
kg body weight per hour through an in-dwelling cannula
in a forearm vein. A heated vein of the contralateral hand
was cannulated and used for blood sampling. Samples were
collected hourly and then every 15 minutes in the last hour
for the assessment of plasma glucose, insulin, amino acids,
and the enrichment of 13C-ketoisocaproate (KIC) and L-[1-
13C] leucine. Samples of expired air were collected at the
same time as the blood samples for the assessment of enrich-
ment of 13CO2.T h er a t eo fC O 2 production was measured
with a ventilated hood system (Delta Trac Respiratory Gas
Monitor,YorbaLinda,CA)duringthelasthourofeachstudy
day.
2.2. Protein Kinetics. The enrichment of L-[1-13C] leucine
and [13C]KIC in plasma was measured as described previ-
ously, for example, [30–32] with a VG MD 800 quadrupole
gas chromatography mass spectrometry (Fisons MD 800,
San Jose, CA). The enrichment of L-[1-13C] leucine wasInternational Journal of Pediatric Endocrinology 3
Table 2: Concentration of amino acids in plasma during consump-
tion of basal diet and basal diet with added leucine.
Amino Acid Basal diet
(μmol/L)
Basal diet+leucine
(μmol/L)
Alanine 780 ±68 645 ±20
Glutamic Acid 74 ±12 78 ±6
Asparagine 134 ±11 107 ±7∗∗
Serine 186 ±25 134 ±9
Glutamine 1096 ±192 959 ±141
Histidine 132 ±8 114 ±6∗∗
Glycine 303 ±73 238 ±23
Threonine 227 ±26 189 ±27
∗∗
Arginine 137 ±6 129 ±9
Aspartic Acid 14.4 ±4.49 .6 ±1.2
Phenylalanine 121 ±12 113 ±6
Tyrosine 192 ±17 151 ±14
∗
Valine 508 ±47 391 ±24
∗
Methionine 117 ±21 102 ±14
Tryptophan 123 ±6 122 ±6
Isoleucine 151 ±17 116 ±10
∗
Leucine 338 ±36 738 ±66
∗∗∗
Lysine 362 ±39 321 ±38
Amino acid concentrations in plasma were determined by HPLC as
d e s c r i b e di nM e t h o d s .T h ed i ﬀerences between the period of consumption
ofthebasaldietandduringconsumptionofthebasaldietwithaddedleucine
are signiﬁcant at ∗P<. 05, ∗∗P<. 01, and ∗∗∗P<. 001.
measured after conversion to the tertiary butyldimethylsilyl-
and [13C]KIC after conversion to the quinoxalinol ter-
tiarybutyldimethylsilyl-derivative.Theenrichmentofbreath
13CO2 was measured by gas isotope ratio-mass spectrometry
at the General Clinical Research Center at the University of
V ermontwithaV GSIRAIII sot o peRatioM assSpectr omet er
(Middlewich, Cheshire, UK) as described previously [33].
The enrichment of plasma KIC was used as a surrogate
for intracellular leucine enrichment [34]. The assessment
of protein metabolism was made from the enrichment of
[13C]KIC and 13CO2 during the last hour of the 6 hours of
feeding. Endogenous leucine ﬂux (Q) was calculated from
rate (i) and the enrichment (Ei) of leucine infused and the
enrichment of plasma KIC (Ep) with the formula below and
corrected for the amount of leucine infused.
Q
μmoleleucine/kg
hr

= i
Ei
Ep
. (1)
The rate of leucine oxidation was derived from the
rate of expired 13CO2 production (breath enrichment of
13CO2 × CO2 production) with correction for incomplete
recovery of CO2 [31]. The rate of protein degradation, in
μmole leucine/kg/hr, was calculated as the rate of ﬂux minus
the rate of leucine intake, and the rate of protein synthesis
was calculated as ﬂux minus oxidation [35]. Net protein
balance was calculated from the diﬀerence between the rate
of protein degradation and the rate of protein synthesis.
2.3. Plasma Insulin and Glucose. The concentration of glu-
cose in plasma was determined with a glucose oxidase
method carried out with a Beckman II Glucose Analyzer.
Plasma insulin concentrations were determined by radioim-
munoassay (Diagnostics Products Corp, Los Angles, CA).
2.4. Biostatistics. All data are expressed as mean ± SEM.
Statistical analysis was performed with a two-tailed paired
t-test for comparison of the data between the periods with
basal diet and with basal diet and supplemental leucine. Dif-
ferences with P values of <. 05 were considered statistically
signiﬁcant.
3. Results
T h es t u d yw a sc o n d u c t e di n6f e m a l es u b j e c t sw i t ham e a n
ageof16±0.4yearswhohadtype1diabetesforadurationof
10±1.52years. (Table 1). Prior to enrollment in the study, all
subjects received insulin through continuous subcutaneous
infusion sets and had variable control of their disease with
hemoglobin A1C values ranging from 7.1–10.5%.
During the two study days, conducted in random order,
subjects received an intravenous infusion of insulin to
maintain plasma glucose. There was no signiﬁcant diﬀerence
in the plasma glucose levels on the day with basal diet
(134 ± 5mg/dL) compared with the day with the basal diet
plus supplemental leucine (143 ± 4), as shown in Figure 1.
However, the amount of insulin required to maintain these
levels of plasma glucose was signiﬁcantly diﬀerent on the
two study days, with greater amounts of insulin required
on the study day with supplemental leucine (36 ± 3 units)
compared with the day when the basal diet was consumed
(30 ± 3 units, P = .02) and higher levels of plasma insulin
(Figure 2).
In response to the consumption of the basal diet with
supplemental leucine, the concentration of leucine in plasma
was signiﬁcantly increased compared to the concentration
during consumption of the basal diet alone (Table 2). There
was a signiﬁcant decrease in the plasma concentration of the
other branched-chain amino acids, isoleucine, and valine, as
well as asparagine, histidine, threonine, and tyrosine.
Provisionofsupplementalleucineinthedietsigniﬁcantly
reduced the enrichment of plasma leucine (2.68 ± 0.07
moles percentexcess)comparedtothe enrichment ofleucine
during the consumption of the basal diet (4.88 ± 0.07, P<
.0001). The enrichment of plasma KIC was also signiﬁcantly
diﬀerent between the 2 days (2.15 ± 0.04 with supplemental
leucine and 3.58 ± 0.06 with the basal diet, P<. 001).
All parameters of whole body protein metabolism (shown
in Figure 3) were calculated from the enrichment of KIC
in the plasma. The rate at which whole-body protein was
synthesized did not diﬀer between the study day when
subjects consumed the basal diet and the study day when
thedietwassupplementedwithadditionalleucineequivalent
four times the amount in the basal diet (102 ± 11μmoles
leucine/kg body weight/hr with supplemental leucine com-
pared to 89.8 ± 5.0 with the basal diet). In contrast, the rate
at which whole-body protein was degraded was signiﬁcantly4 International Journal of Pediatric Endocrinology
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Figure 2: Plasma insulin concentrations in type 1 diabetic
adolescent girls consuming a basal diet or a diet supplemented
with L-leucine. Plasma concentrations of insulin (mU/L) during
consumption of the basal diet (19% of calories from fat, 57% of
calories fromcarbohydrate, and 22% fromprotein)or the basal diet
with supplemental L-leucine (total leucine content of 4 times the
basal diet).
reduced when the diet was enriched with leucine (49.5 ± 19
versus 109±13μmoles leucine/kg body weight/hr, P<. 001).
The rate of leucine oxidation was signiﬁcantly higher when
additional leucine was added to the diet as is to be expected
(179 ± 14 versus 71.6 ± 6.9, P<. 001). Protein balance or
the net accretion of body protein, that is, the rate at which
protein was synthesized relative to the rate at which protein
was degraded was signiﬁcantly improved with the addition
of supplemental leucine to the basal diet (52.8 ± 12.2v e r s u s
−19.3 ±10.6, P<. 001).
4. Discussion
This study was undertaken to determine if supplemental
leucine could maximize the utilization of dietary protein
in type 1 diabetic adolescents. If an anabolic eﬀect were
observed, the study also had the potential to provide infor-
mation about the importance of insulin in mediating the
eﬀect of leucine in the human context, since these subjects
were unable to increase circulating insulin concentrations in
response to supplemental dietary leucine. This acute study,
conducted over two study days of 6 hours each, suggests
that supplemental dietary leucine equivalent to four times
the leucine content of the basal diet may improve the net
accumulation of whole-body protein through a decrease in
the rate at which protein is degraded. The study design to
examine the acute response (between 5-6h) to supplemental
dietary leucine was chosen so that the results would be
somewhat comparable to animal studies (e.g., [2, 27, 28, 36–
38]) examining this same phenomenon. Sequential study
days were used to compare the responses to the basal diet
with responses to the leucine-supplemented diet: a study
design which minimized potentially confounding variables
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Figure 3: Leucine kinetics in type 1 diabetic adolescent girls
consuming a basal diet or a diet supplemented with L-leucine.
Protein synthesis, protein degradation, leucine oxidation, and
protein balance were calculated from the enrichment of plasma
[13C]KIC, 13CO2,a n dC O 2 production as described in Materials
and Methods. The data are expressed as μmoles of leucine/kg body
weight/h during consumption of the basal diet (19% of calories
fromfat,57%ofcaloriesfromcarbohydrate,and22%fromprotein)
or the basal diet with supplemental L-leucine (total leucine content
of 4 times the basal diet). Diﬀerences between the study day with
the basal diet and the study day with the basal diet supplemented
with L-leucine were statistically signiﬁcant, ∗P<. 001.
such as stage of menstrual cycle or alterations in exercise
regimen between study days. Since the acute eﬀects on
protein metabolism associated with feeding are unlikely
to extend through the overnight fasting period into the
following day, it is unlikely that there was a carry-over eﬀect
on the second study day from the diet consumed on the
ﬁrst study day. However, to avoid such a potential, study
days were randomized with respect to the order of leucine-
supplemented or basal diet as the ﬁrst study day.
Both insulin and dietary protein (i.e., amino acids) have
an anabolic eﬀect on protein metabolism, but animal studies
have suggested that leucine alone also has the ability to
augment the anabolic eﬀect of insulin on the synthesis of
muscle protein (e.g., [2, 27]). Further studies have suggested
that leucine has an anabolic eﬀect on muscle protein
synthesis in diabetic animals suggesting that at least a part of
the leucine eﬀect is independent of insulin [28]. In animal
studies, the insulin-mediated eﬀect of leucine on protein
synthesis is mediated through a mechanism involving the
regulation of mRNA translation initiation [27, 36–38] while
the mechanism of the insulin-independent eﬀect is not
known.
Studies in adults with type 1 diabetes have suggested
that the anabolic eﬀect of insulin on whole-body protein
metabolism, particularly protein synthesis, is inﬂuenced by
the supply of amino acids as well as insulin (e.g., [8, 39]).
In healthy subjects, a complete mixture of amino acids is
not required; just the essential amino acids are suﬃcient
to stimulate the rate of protein synthesis in muscle tissue
[23, 24]. Studies in elderly subjects suggest that leucineInternational Journal of Pediatric Endocrinology 5
speciﬁcally plays an important role in the regulation of the
rate of synthesis of muscle tissue [25, 26]. The current study
in type 1 adolescents also suggests an anabolic eﬀect of
leucine on protein metabolism, but with more of an impact
on the rate at which protein is degraded rather than the
rate at which protein is synthesized. However, the present
study measured whole-body rather than the speciﬁc eﬀects
in muscle tissue.
Although it was anticipated that the leucine would
have the ability to stimulate protein synthesis in subjects
with insulin-dependent diabetes in line with the studies
from diabetic animals [28], this was not the case. Rather
a heretofore unreported eﬀect of supplemental dietary
leucine to induce hyperglycemia compared to the glucose
concentrations which were observed with the consumption
of the basal diet without additional leucine. Experimentally,
sincethesesubjectsareunabletoincreaseinsulinsecretionto
oﬀset the increase in the concentration of plasma glucose, an
increaseintheinfusionofexogenousinsulinwasnecessaryto
maintain plasma glucose concentrations at the desired levels.
Since nutritional supplements like leucine are available over-
the-counter and touted as anabolic agents, the potential for
supplemental leucine to aﬀect not only protein metabolism
but also glucose metabolism is clinically important. This
eﬀect of leucine to increase the concentration of plasma glu-
cose in human subjects is somewhat surprising given animal
studies reporting that leucine increases tissue sensitivity to
insulin, at least in muscle tissue (e.g., [2, 27, 36–38]).
There are a number of limitations to the present study.
Firstly, this study measured the responses of whole-body
protein metabolism rather than the speciﬁc eﬀect of leucine
onmuscletissue.However,astudyexaminingmuscleprotein
synthesis from biopsy specimens would not be ethical in
this adolescent population. Secondly, the study examined
only six subjects. Nevertheless, the observed eﬀect of dietary
supplementation with leucine on net protein balance was
quite large. A retrospective power calculation of the number
ofsubjectsneededtoshowaneﬀectofthissizeandvariability
with 80% power and a two-sided signiﬁcance level of 0.05
is only 3, suggesting validity of the conclusion despite the
small number of subjects. A third limitation of the study is
the variability in glycemic control of the subjects. Although
it is not possible to determine with certainty that long-term
glycemiccontroldoesnotaﬀecttheacuteresponseofprotein
metabolism to dietary intake, the data suggest that this is not
the case. The improvement in protein balance with leucine
supplementation was similar (66.8μmoles of leucine/kg
body weight/h) to that of the three subjects with poorer
glycemic control (77.1μmoles of leucine/kg body weight/h
in subjects with HdA1c 8.9–10.5). In conclusion, this acute
study of 6 hours of feeding supplemented with leucine
suggests a positive role for whole-body protein balance.
Now it is important to ascertain if longer-term studies with
supplemental dietary leucine can provide improvement in
lean body mass. However, these longer-term studies must
alsodeterminetheeﬀectofprolongedleucineadministration
on the concentration of plasma glucose and whether or not
there is a need to increase exogenous insulin with leucine
administration.
Abbreviations
KIC: α-ketoisocaproate.
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